Мединсайт
Посмотреть все-
New update to Candidate List of Substances of Very High Concern (SVHCs)
On 7th November 2024, the ECHA (European Chemicals Agency) released the new Candidate List of SVHCs with the addition of one new substance. The current list of SVHCs now contains 242 substances.GarciaYbrahim -
Surging Demand for Reusable Digital Ovulation Tests: Accuracy Meets Convenience
The market demand for reusable digital ovulation tests is on the rise, driven by growing consumer awareness around fertility tracking, interest in sustainable health products, and advancements in digital health technologies.GarciaYbrahim -
Emerging Solutions to Address The Environmental Impact of Pregnancy Tests
Disposable digital pregnancy tests add to the plastic waste crisis through e-waste, non-recyclable materials, and toxic batteries. Emerging sustainable options like reusable and biodegradable tests offer greener, eco-friendly alternatives to reduce this environmental impact.GarciaYbrahim -
The IVDR extension amendment bill was officially published in the EU Official Journal
The IVDR transition period has been extended, allowing importers to continue selling products certified under the previous IVDD directive. This extension provides more time to comply with labeling, documentation, and certification requirements, minimizing non-compliance risks and maintaining market access.
GarciaYbrahim -
Technological Innovation in the Medical Device Industry: A 2024 Overview
Discover how AI, wearables, and cutting-edge diagnostics are driving innovation in the medical device industry in 2024, reshaping healthcare delivery while navigating regulatory and cybersecurity challenges.GarciaYbrahim -
EU releases Q&A document on IVDR transition period extension and MDR transition period extension Q&A document update
The European Commission has released a Q&A document regarding the extension of the IVDR transition period, as well as an updated Q&A document on the extension of the MDR transition period, pursuant to Regulation 2024/1860, which was recently published.GarciaYbrahim
Новости компании
Посмотреть все-
COP29: A Milestone in Global Climate Action and the Journey to Carbon Reduction
The 29th Conference of the Parties (COP29) concluded in Baku, Azerbaijan, marking a significant milestone in the global effort to combat climate change. This year's conference emphasized transparency, international cooperation, and financial commitments essential for global climate resilience.
GarciaYbrahim -
Achieving ISO 9001 Certification: A Milestone in Our Commitment to Quality
We are proud to announce that MedAsia Healthcare has successfully obtained ISO 9001 certification, a significant achievement that reinforces our commitment to delivering high-quality products and services to our customers.GarciaYbrahim -
Start with me:Everyone should learn CPR first aid skills
In emergencies, every second counts, especially during cardiac arrest, where immediate action can mean the difference between life and death. Cardiopulmonary Resuscitation (CPR) is a simple yet vital skill that everyone should learn.
GarciaYbrahim -
Welcoming Visit Our Company and Bulid Stronger Relationship
At MedAsia, we believe that inviting our customers to visit us is a vital part of building stronger, more collaborative relationships. Recently, we had the pleasure of hosting our valued customer Mr.Nielsen,our team was excited to welcome Mr.Nielsen and his son to our company.
GarciaYbrahim -
Welcoming MR.ANDERS Visit to MedAsia and Factory Tour
On April 25, 2024, MedAsia Healthcare was delighted to welcome Mr. Anders for a significant visit, acknowledging our strong partnership. We engaged in in-depth discussions about shared goals, innovative strategies, and advancements in medical technology, which have strengthened our future collaboration.BertheChris -
Приветствуя MR. M. ИМРАН МАНА: Ценный визит в MedAsia
Наша недавняя встреча с г-ном Маной из MANA & CO. была больше, чем просто деловым обменом; она подчеркнула непреходящую ценность партнерства и потенциал общего видения.Omega
- Подписаться MedInsights
- Подписаться MedInsights
- Подписаться MedInsights
- Подписаться MedInsights
- Подписаться MedInsights
- Подписаться MedInsights
- Подписаться MedInsights
- Подписаться MedInsights
- Подписаться MedInsights
- Подписаться MedInsights